RBI-X000

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameRBI-X000
Drug Alias NameSelf-replicating RNA therapyRBI-X000
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionRNA modulators
TargetsRibonucleic Acid
Therapy Area/IndicationsObesityCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesReplicate Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesNovo Nordisk A/SReplicate Bioscience Inc
Inactive CompaniesN/A
Active IndicationsObesityCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A